Severe Disease & Prevention Targeting postprandial glucose spikes is associated with reduced atherogenic stress and may slow progression of microvascular complications (retinopathy, neuropathy) and macrovascular disease , lowering long-term cardiovascular risk
With healthcare providers prioritizing effective and long-term solutions for metabolic diseases, GLP-1 therapies have gained widespread acceptance
Copper peptides are unlikely to cause hyperpigmentation and may actually help reduce it by promoting even skin tone and cellular turnover
When you cycle back on, your sensitivity to the peptides is diminished, and then you get the most impact from the money spent
In an email, Genna Hymowitz, director of metabolic and bariatric psychology and a clinical associate professor at Stony Brook Medicine, said more research was needed "before we prescribe GLP-1s to people who are not overweight, and we need to better understand the long-term risks of GLP-1s